Skip Navigation

U.S. Department of Health & Human Services
Navigation to Home, Contact Us, Site Map, About REMM
Radiation Event Medical Management (REMM)
REMM Banner
Search REMM Web Site
What Kind of Emergency? Initial Event Activities Patient Management Algorithms Management Modifiers Tools & Guidelines

REMM Home Contact Us Site Map About REMM
 

You are here: Home > Managing Internal Contamination > Potassium Phosphate, Dibasic


 
  Features
  Quick Links
  Other Web Resources
 

Potassium Phosphate, Dibasic



Indications and Usage


  • This drug can be used to block uptake of radioactive phosphate. The medication K-Phos® Neutral contains 250 mg phosphorus per tablet.
  • Usual adult dose is 1-2 tabs p.o. qid, with full glass of water each time, with meals and at bedtime.
  • Pediatric patients over 4y, 1 tab qid.
  • Contraindicated in hyperphosphatemia, renal insufficiency, and infected phosphate stones.

FDA Product Safety Info

  • Not FDA approved for this indication/off-label use

top of page



References

  1. Marcus, CS. Administration of decorporation drugs to treat internal radionuclide contamination: medical emergency response to radiologic incidents. RSO Magazine, 2004;9(5):9-15. (PDF - 34 KB)
  2. "Radiation Bioterrorism," Tochner ZA, Lehavi O, Glatstein E, Chapter 207 in Harrison's Principles of Internal Medicine, Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. 16th Edition, pp 1294-1300, McGraw-Hill, 2005
  3. Management of Persons Accidentally Contaminated with Radionuclides, National Council on Radiation Protection and Measurements, NCRP Report No. 65, Bethesda, MD, 1980.
 

US Department of Health & Human Services     
U.S. Department of Health & Human Services Office of the Assistant Secretary for Preparedness and Response National Library of Medicine